Vascular networks are required to support the formation and function of three-dimensional tissues. Biodegradable scaffolds are being considered in order to promote vascularization where natural regeneration of lost or destroyed vascular networks fails. Particularly; composite materials are expected to fulfill the complex demands of a patient's body to support wound healing. Microbial biopolyesters are being regarded as such second and third generation biomaterials. Methylobacterium extorquens is one of several microorganisms that should be considered for the production of advanced polyhydroxyalkanoates (PHAs). M. extorquens displays a distinct advantage in that it is able to utilize methanol as an inexpensive substrate for growth and biopolyester production. The design of functionalized PHAs, which would be made of both saturated short-chain-length (scl, C [less than or equal to] 5) and unsaturated medium-chain-length (mcl, 6 [less than or equal to] C [less than or equal to] 14) monomeric units, aimed at combining desirable material properties of inert scl/mcl-PHAs with those of functionalized mcl-PHAs. By independently inserting the phaC1 or the phaC2 gene from Pseudomonas fluorescens GK13, recombinant M. extorquens strains were obtained which were capable of producing PHAs containing C-C double bonds. A fermentation process was developed to obtain gram quantities of biopolyesters employing the recombinant M. extorquens ATCC 55366 strain which harbored the phaC2 gene of P. fluorescens GK13, the better one of the two strains at incorporating unsaturated monomeric units. The PHAs produced were found in a blend of scl-PHAs and functionalized scl/mcl-PHAs (4 [less than or equal to] C [less than or equal to] 6), which were the products of the native and of the recombinant PHA synthase, respectively. Thermo-mechanical analysis confirmed that the functionalized scl/mcl-PHAs exhibited the desirable material properties expected. This project contributed to current research on polyhydroxyalkanoates at different levels. The terminal double bonds of the functionalized scl/mcl-PHAs are amenable to chemical modifications and could be transformed into reactive functional groups for covalently linking other biomacromolecules. It is anticipated that these biopolyesters will be utilized as tissue engineering materials in the future, due to their functionality and thermo-mechanical properties.

Insect pests represent major threats to food production, biodiversity conservation, and human and animal health. Currently, the most widespread strategy to control their populations is through the spraying of synthetic chemical insecticides. However, the overuse of these compounds has had significant negative environmental consequences. Additionally, our reliance on insecticides has resulted in major reductions in their efficacy through pest-evolved resistance. To successfully manage insect pests, while avoiding environmental degradation, thus requires the development of novel, more sustainable, pest management strategies. Recent advances in our understanding of recombinant DNA methods and molecular biology have allowed the application of transgenic tools to pest management. Here, synthetic genes can be engineered, transformed into the genomes of pest species, and transported into wild target populations through the natural mating behaviour of the insect. A strategy in which these transgenes are lethal to those insects inheriting them in the field is known as RIDL – Release of Insects carrying a Dominant Lethal. A variant of RIDL limits this lethality to females – female specific RIDL (fsRIDL) – which explicitly targets the reproductive capacity of a target population. The aim of this thesis is to investigate the application of such an fsRIDL strategy to the diamondback moth (Plutella xylostella L.). This economically important pest of brassica crops is highly adept at developing resistance to insecticides and is considered extremely difficult to manage effectively. I present findings which demonstrate the power of diamondback moth lines transformed with fsRIDL transgenes to eliminate target pest populations, and combine synergistically with other transgenic control strategies such as Bt crops in counteracting the evolution of pesticide resistance. Additionally, an exploration into an alternative gene expression system to that used in current RIDL strategies – the Q system – suggests that not all expression systems will be suitable for transgene control within this highly specific framework. It is hoped that this work will contribute towards the effective control of the diamondback moth, and form a model for the sustainable control of other lepidopteran species through genetic pest management.

This thesis discusses the detrimental effects that industrialized farming practices have on public health, animal welfare, and ecological systems and includes factual support. It also provides practical application of this information as well as possible solutions and a detailed description of a related art exhibition.

In 2003 the United States filed an official complaint against the European Community at the World Trade Organization in regards to the ban imposed on GM crops within the EU, saying that there was no scientific defense for their point of view, and this had created barriers to trade. After one of the longest dispute settlement in WTO history, the body sided with the US and deemed the ban to be restricting free trade. Conflicting research on the safety of GM crops has further complicated the matter and many members of the EU are still choosing to ban GM crops in defiance of the WTO ruling.

The subject of my thesis was to genetically modify a potato for increased resistance against its pathogens and pests. In developing a resistant plant, it is quite common to use the same type of molecules that plants use themselves in their defense reactions. In this work I used the gene SPI-2 originating from a honeycomb moth (Galleria mellonella). The protein SPI-2 is a member of serine protease inhibitors. Since the previous attempts of the team to detect the protein in transformed plants haven't been successful, the basic form of the gene was modified by adding a Kozak sequence near the start codon, which should have increased the translation initiation and hence increase the level of the protein. Two constructs were prepared for the transformation: SPI-2-T a SPI-2-Y. They differ by one amino acid, which slightly changes their inhibitory activity. First, the construct SPI-2-T was used for a transient transformation of tobacco Nicotiana benthamiana by agroinfiltration of its leaves. Then both constructs were used for a stable transformation of Solanum tuberosum cv. Desireé. The detection of the protein has not been successful, although the inserted gene was transcribed and his sequence was verified by sequencing. It is therefore most likely that the protein has a low stability in the cytoplasm....

No description available.

Les mycobactéries sont classées parmi les bactéries contenant des acides mycoliques dans leur paroi et un haut GC% dans leur génome. Elles peuvent être isolées à partir du sol ou d'environnement d'eau douce où vivent aussi les protozoaires libres. Plusieurs études ont montré une possibilité de co-isolement des mycobactéries et des amibes à partir de ces sources environnementales. Il a été montré également que la plupart des mycobactéries de l'environnement ont la capacité à survivre dans les trophozoites et les kystes d'amibes et dans certaines cellules eucaryotes, y compris les macrophages. Les manipulations génétiques des mycobactéries en général et des mycobactéries du complexe Mycobacterium tuberculosis en particulier sont compliquées et aucune étude de modification génétique des mycobactéries (pathogènes ou non pathogènes) n'avait été réalisée dans notre laboratoire avant notre travail de thèse. Dans notre travail de thèse, nous avons montré que les amibes ou d'autres organismes phagocytaires peuvent servir comme sources et lieu de transfert des gènes chez les mycobactéries. Ce transfert des gènes peut avoir contribué à l'adaptation des mycobactéries à un mode de vie intracellulaire. Nous avons développé ensuite deux systèmes de coculture: Mycobacterium smegmatis-Acanthamoeba polyphaga et Mycobacterium gilvum-A. polyphaga et nous avons clarifié le spectre des interactions des mycobactéries à croissance rapide avec les amibes. Ce modèle d'interaction mycobactéries-amibes a été utilisé pour tester l'hypothèse contraire au paradigme dominant que l'addition des gènes réduit la virulence des bactéries. / Mycobacteria are mycolic-acid containing, high GC% bacterial organisms which can be recovered from soil and fresh water environments where free-living protozoa also live. Co-isolation of mycobacteria and amoeba collected from such environmental sources has been reported. Several experiments further demonstrated the ability of most environmental mycobacteria to survive in the amoebal trophozoites and cysts and in some eukaryotic cells including macrophages. Genetic modification of mycobacteria in general and mycobacteria belonging to Mycobacterium tuberculosis complex in particular are complicated and no studies using genetic modification of mycobacteria (pathogenic or non-pathogenic) had been performed in our laboratory prior to our work. In our thesis work, we showed that amoebae or other phagocytic organisms can serve as sources and places for gene transfers in mycobacteria. Gene transfers may have contributed to the adaptation of mycobacteria to an intracellular lifestyle. In addition, we developed two co-culture systems: Mycobacterium smegmatis-Acanthamoeba polyphaga and Mycobacterium gilvum-A. polyphaga and we clarified the spectrum of rapid-growing mycobacteria and amoeba interactions. This model of mycobacteria-amoeba interactions was then used to test another hypothesis according to which unlike the prevailing paradigm, the addition of genes does not reduce the virulence of bacteria. For the first time in our laboratory we modified two species of the M. tuberculosis complex, M. tuberculosis H37Rv and Mycobacterium bovis BCG to observe the effect of these changes on their pathogenicity and survival.

The involvement of mitochondrial signaling in mammalian PCD regulation has been examined extensively via biochemical analyses and cellular studies in vitro. However there still exist considerable gaps in our knowledge regarding its contribution in specific tissues and cell types during mammalian development in vivo. In addition, given the numerous pathologic conditions associated with aberrant PCD, modulation of this signaling process represents an attractive target for therapeutic intervention. In this thesis I have therefore examined the regulation of mitochondrion-mediated PCD signaling as it pertains to several forms of developmental and injury-induced cell death. In the first component of the thesis I have examined the differential sensitivity of Bcl2 on the survival of motor neuron populations from two distinct developmental origins (alpha and gamma motor neurons), demonstrating that gamma motor neurons are preferentially affected in Bcl2 null mice. Thus, Bcl-2 plays a critical in vivo in regulating subtype-specific motor neuron survival during development. In the second study I have demonstrated that a major portion of the neuroprotective effect exerted by the immunophilins cyclosporin A and FK-506 are mediated through calcineurin signaling; rather than MOMP-mediated events as previously held. Additional findings of this study demonstrated the first neuroprotective effects of the pyrethroid insecticide cypermethrin and calcineurin-mediated control of Bad phosphorylation. Such findings establish a link between calcineurin signaling and mitochondrion-mediated cell survival. The above studies established critical features of mitochondrion-mediated PCD in regulating survival of several neuronal subpopulations. I therefore followed these studies with an examination of how post-mitochondrial PCD signaling is regulated following MOMP permeabilization. Specifically I examined regulation of the Smac-IAP-caspase axis, investigating how combinatorial deletion of Casp3 and Diablo alter PCD progression in mouse embryonic fibroblasts. Using a series of injury stimuli in the context of biochemical and cellular analyses I have developed a model of how endogenous Smac/DIABLO regulates executioner caspase activity. Collectively these studies elucidate key aspects of mitochondrial signaling during both developmental and injury-induced PCD in vivo.

The involvement of mitochondrial signaling in mammalian PCD regulation has been examined extensively via biochemical analyses and cellular studies in vitro. However there still exist considerable gaps in our knowledge regarding its contribution in specific tissues and cell types during mammalian development in vivo. In addition, given the numerous pathologic conditions associated with aberrant PCD, modulation of this signaling process represents an attractive target for therapeutic intervention. In this thesis I have therefore examined the regulation of mitochondrion-mediated PCD signaling as it pertains to several forms of developmental and injury-induced cell death. In the first component of the thesis I have examined the differential sensitivity of Bcl2 on the survival of motor neuron populations from two distinct developmental origins (alpha and gamma motor neurons), demonstrating that gamma motor neurons are preferentially affected in Bcl2 null mice. Thus, Bcl-2 plays a critical in vivo in regulating subtype-specific motor neuron survival during development. In the second study I have demonstrated that a major portion of the neuroprotective effect exerted by the immunophilins cyclosporin A and FK-506 are mediated through calcineurin signaling; rather than MOMP-mediated events as previously held. Additional findings of this study demonstrated the first neuroprotective effects of the pyrethroid insecticide cypermethrin and calcineurin-mediated control of Bad phosphorylation. Such findings establish a link between calcineurin signaling and mitochondrion-mediated cell survival. The above studies established critical features of mitochondrion-mediated PCD in regulating survival of several neuronal subpopulations. I therefore followed these studies with an examination of how post-mitochondrial PCD signaling is regulated following MOMP permeabilization. Specifically I examined regulation of the Smac-IAP-caspase axis, investigating how combinatorial deletion of Casp3 and Diablo alter PCD progression in mouse embryonic fibroblasts. Using a series of injury stimuli in the context of biochemical and cellular analyses I have developed a model of how endogenous Smac/DIABLO regulates executioner caspase activity. Collectively these studies elucidate key aspects of mitochondrial signaling during both developmental and injury-induced PCD in vivo.

En aquest treball es descriu el disseny, síntesi i caracterització de diferents biomaterials i la seva possible aplicació en biomedicina. S'ha fet especial èmfasi a ressaltar la importància que tenen l'estructura, la composició i l'activitat superficial en les propietats finals del biomaterial. Així, s'ha desenvolupat un biomaterial biodegradable i elastomèric, altament porós, amb una gran interconnectivitat que permet la difusió de nutrients i de cèl•lules, un cop sigui implantat. La viabilitat d'aquest material s'ha demostrat tant en assaigs in vitro com in vivo. La síntesi del mateix s'ha realitzat mitjançant calefacció assistida per microones, cosa que ha permès una reacció més ràpida sense necessitat de catalitzadors i evitant les etapes posteriors de purificació. S'ha desenvolupat també un material biodegradable i injectable a temperatures de 45°C, que, en refredar fins als 37°C, s'endureix i pot emprar com a suport estructural al mateix temps que actua com a alliberador de fàrmacs. L'aplicació d'aquest material com ciment ossi millora els problemes de biocompatibilitat, tant de composició, com mecànica, dels actuals productes en el mercat, obrint una nova via d'aplicació d'aquest tipus de materials. D'altra banda, el compost desenvolupat s'ha assajat en aplicacions bioadhesives, on ha demostrat uns excel•lents resultats en la unió de teixit intestinal. Finalment, s'ha aconseguit desenvolupar una superfície amb capacitat de reprogramar cèl•lules amb el simple contacte entre la cèl•lula i la superfície. Amb aquesta tecnologia, anomenada cell reprograming surface (CRS), s'han obtingut cèl•lules pluripotents induïdes (iPS) d'una forma molt més eficient i ràpida que els mètodes habituals de treball. / En este trabajo se describe el diseño, síntesis y caracterización de diferentes biomateriales y su posible aplicación en biomedicina. Se ha hecho especial énfasis en resaltar la importancia que tienen la estructura, la composición y la actividad superficial en las propiedades finales del biomaterial. Así, se ha desarrollado un biomaterial biodegradable y elastomérico, altamente poroso, con una gran interconectividad que permite la difusión de nutrientes y de células, una vez sea implantado. La viabilidad de este material se ha demostrado tanto en ensayos in vitro como in vivo. La síntesis del mismo se ha realizado mediante calefacción asistida por microondas, lo que ha permitido una reacción más rápida sin necesidad de catalizadores y evitando las etapas posteriores de purificación. Se ha desarrollado también un material biodegradable e inyectable a temperaturas de 45°C, que, al enfriarse hasta los 37°C, se endurece y puede emplearse como soporte estructural a la vez que actúa como liberador de fármacos. La aplicación de dicho material como cemento óseo mejora los problemas de biocompatibilidad, tanto de composición como mecánica, de los actuales productos en el mercado, abriendo una nueva vía de aplicación de este tipo de materiales. Por otro lado, el compuesto desarrollado se ha ensayado en aplicaciones bioadhesivas, donde ha demostrado unos excelentes resultados en la unión de tejido intestinal. Por último, se ha conseguido desarrollar una superficie con capacidad de reprogramar células con el simple contacto entre la célula y la superficie. Con esta tecnología, denominada cell reprograming surface (CRS), se han obtenido células pluripotentes inducidas (iPS) de una forma mucho más eficiente y rápida que los métodos habituales de trabajo. / This paper describes the design, synthesis and characterization of different biomaterials and their possible applications in biomedicine, highlighting the importance of the structure, composition and surface activity in the final properties of the biomaterial. Thus, a biodegradable and elastomeric biomaterial, highly porous, with a strong interconnectivity that allows diffusion of nutrients and cells, once it is implanted has been developed. The feasibility of this material has been demonstrated both in vitro and in vivo assays. The synthesis has been performed using microwave-assisted heating, which has allowed a faster reaction without catalysts and avoiding the later stages of purification. It has also been developed a biodegradable and injectable material, at temperatures of 45°C, which, when cooled to 37°C, it hardens and can be used as structural support while acting as drug delivery. The application of such material as bone cement avoid biocompatibility problems, both in composition and mechanicas, of the current products on the market, opening a new way of application of such material. On the other hand, the compound has been tested in bioadhesive applications, where it has shown excellent results in the union of intestinal tissue. Finally, a surface with ability to reprogram cells with simple contact between the cell and the surface has been developed. With this technology, called cell reprograming surface (CRS), induced pluripotent cells (iPS) have been obtained in a much more efficient and faster way than the usual methods.